As China becomes a rapidly growing pharmaceutical industry, The 9th DPI China Technology Conference presents an opportunity for new technology, market trends and regulatory requirements of DPI development to be explored and discussed by the industry’s leading experts and professionals.

H&T Presspart’s Dr Xi Yang will be taking part in this year’s event and will be delivering a speech on the 26th March entitled “The Dry Powder Inhalers: Affordability Versus High Performance” at 15.20 – 15.50 local time.

In developing markets, where demand for respiratory treatments is growing rapidly, there’s an increasing need to offer more choice to patients who use a dry powder inhaler (DPI). PowdAir Plus is a patented capsule-based DPI, ideal for these markets because of its advanced simplicity, ease of use and affordability.

H&T Presspart's PowdAir Plus dry powder inhaler device.
H&T Presspart’s PowdAir Plus dry powder inhaler device.

 

As well as PowdAir Plus, H&T Presspart will also be showcasing our extensive range of respiratory drug delivery components including MDI canisters and actuators. In addition, there will also be information about H&T Presspart’s Inhalation Product Technology Centre (IPTC) which provides our customers with bespoke and operational project support in three key areas of developing new devices and components, developing new products, and analytical support.

For any more information or to arrange a meeting with Dr Xang during the conference then please contact us.